In a mouse model of allergic asthma, administration of anti-B7-H3 mAbs significantly reduced airway hyperactivity and resulted in decreased production of Th2 cytokines (interleukin-4 (IL-4), IL-5, and IL-13) as compared with control IgG-treated mice [33]. This evidence concerns the gene IL4 and allergic asthma.